Skip to content
Open global navigation

Cambridge University Press

AcademicLocation selectorSearch toggleMain navigation toggle

Your Cart


You have 0 items in your cart.

Register Sign in Wishlist
Look Inside Incentives for Global Public Health

Incentives for Global Public Health
Patent Law and Access to Essential Medicines


Part of Connecting International Law with Public Law

Thomas Pogge, Matthew Rimmer, Kim Rubenstein, Rochelle Cooper Dreyfuss, Andrew Mitchell, Tania Voon, Hitoshi Nasu, Elizabeth Siew Kuan Ng, Kathleen Liddell, William W. Fisher, Talha Syed, Thomas Faunce, Dianne Nicol, Jane Nielsen, Charles Lawson, Barbara Hocking, Noah Benjamin Novogrodsky, Katharine Young, Rajshree Chandra, Jonathan Burton-MacLeod
View all contributors
  • Date Published: July 2010
  • availability: In stock
  • format: Hardback
  • isbn: 9780521116565
Average user rating
(1 review)


Add to cart Add to wishlist

Other available formats:

Looking for an examination copy?

If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact providing details of the course you are teaching.

Product filter button
About the Authors
  • This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.

    • Connects international and public law, extending each discipline's understanding of the other
    • Explores institutional mechanisms that would create additional incentives to develop essential medicines while also ensuring real access to the new products even for the world's poorest populations
    • Provides policy impetus to those working in the area of global health
    Read more

    Customer reviews


    This is a well edited collection from leading international scholars on the subject of global health, one that provides comprehensive analysis on the role of innovation in promoting health. Although the literature on this subject is vast, this volume presents new and challenging insights. Short, focussed chapters cover a good breadth of topics and shed fresh and clear light on the public side of the debate on access to essential medicines.

    Review was not posted due to profanity


    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?


    Product details

    • Date Published: July 2010
    • format: Hardback
    • isbn: 9780521116565
    • length: 536 pages
    • dimensions: 235 x 158 x 29 mm
    • weight: 0.98kg
    • availability: In stock
  • Table of Contents

    Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein
    Part I. International Trade:
    1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss
    2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon
    3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu
    4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng
    Part II. Innovation:
    5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge
    6. The Health Impact Fund: a critique Kathleen Liddell
    7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed
    8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce
    Part III. Intellectual Property:
    9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen
    10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas
    11. Accessing and benefit sharing avian influenza viruses through the World Health Organization: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking
    12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer
    Part IV. Health-Care:
    13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky
    14. Securing health through rights Katharine Young
    15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra
    16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod.

  • Editors

    Thomas Pogge, Yale University, Connecticut
    Thomas Pogge is Leitner Professor of Philosophy and International Affairs at Yale University, Professorial Fellow at the ANU Centre for Applied Philosophy and Public Policy (CAPPE), and Research Director at the Oslo University Centre for the Study of Mind in Nature (CSMN).

    Matthew Rimmer, Australian National University, Canberra
    Matthew Rimmer is a senior lecturer and associate director of research at the ANU College of Law, and an associate director of the Australian Centre for Intellectual Property in Agriculture.

    Kim Rubenstein, Australian National University, Canberra
    Kim Rubenstein is Professor and Director of the Centre for International and Public Law (CIPL) in the ANU College of Law, Australian National University.


    Thomas Pogge, Matthew Rimmer, Kim Rubenstein, Rochelle Cooper Dreyfuss, Andrew Mitchell, Tania Voon, Hitoshi Nasu, Elizabeth Siew Kuan Ng, Kathleen Liddell, William W. Fisher, Talha Syed, Thomas Faunce, Dianne Nicol, Jane Nielsen, Charles Lawson, Barbara Hocking, Noah Benjamin Novogrodsky, Katharine Young, Rajshree Chandra, Jonathan Burton-MacLeod

Sign In

Please sign in to access your account


Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website, your eBook purchase and download will be completed by our partner Please see the permission section of the catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Find content that relates to you

Back to top

Are you sure you want to delete your account?

This cannot be undone.

Cancel Delete

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

Please fill in the required fields in your feedback submission.